Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

• Unité de recherche: INNOSUISSE
• Numéro de projet: 13731.1;6 PFFLM-LS
• Titre du projet anglais: Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

Description succincte (Allemand)

Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

Description succincte (Anglais)

Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

Résumé des résultats (Abstract) (Allemand)

The Qstent, a small metal mesh tube, being implanted into coronary arteries to prevent heart attacks, combines the current advantages of drug-eluting stents (reduced re-narrowing risk) with those of bare metal stents (fast ingrowth; hence reduced thrombosis risk). It therefore shows clear clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti coagulant drug therapies and cumbersome re-interventions.

Résumé des résultats (Abstract) (Anglais)

The Qstent, a small metal mesh tube, being implanted into coronary arteries to prevent heart attacks, combines the current advantages of drug-eluting stents (reduced re-narrowing risk) with those of bare metal stents (fast ingrowth; hence reduced thrombosis risk). It therefore shows clear clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti coagulant drug therapies and cumbersome re-interventions.